Telegram channel "Dr Pulkits ENT Updates" — @drpulkitent

Dr Pulkits ENT Updates

30 Nov 2020, 18:04

00:00

Video is unavailable for watching

Show in Telegram

62 2 0

Dr Pulkits ENT Updates

23 Nov 2020, 07:01

https://www.moneycontrol.com/news/coronavirus/bharat-biotech-says-its-covid-19-vaccine-will-have-60-efficacy-6145051.html

Bharat Biotech says its COVID-19 vaccine will have 60% efficacy

Covaxin is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

174 0 0

Dr Pulkits ENT Updates

18 Nov 2020, 21:07

https://www.medgadget.com/2019/12/osia-a-new-type-of-implantable-hearing-solution-by-cochlear-secures-fda-clearance-interview.html

Osia, a New Type of Implantable Hearing Solution by Cochlear, Secures FDA Clearance: Interview | Medgadget

530 0 0

Dr Pulkits ENT Updates

18 Nov 2020, 15:00

https://www.medgadget.com/2020/01/orcam-camera-and-hearing-buds-combo-intelligently-amplify-speech-ces-2020.html

OrCam Camera and Hearing Buds Combo Intelligently Amplify Speech: CES 2020 | Medgadget

400 0 0

Dr Pulkits ENT Updates

2 Nov 2020, 17:12

Forward from: Pulkit Agarwal

486 0 0

Dr Pulkits ENT Updates

2 Nov 2020, 17:12

Forward from: Pulkit Agarwal

430 0 0

Dr Pulkits ENT Updates

2 Nov 2020, 17:12

Forward from: Pulkit Agarwal

356 0 0

Dr Pulkits ENT Updates

2 Nov 2020, 16:55

Details to be posted soon

322 0 0

Dr Pulkits ENT Updates

2 Nov 2020, 03:18

https://www.livemint.com/science/health/india-s-first-covid-19-vaccine-to-launch-in-second-quarter-of-2021-phase-iii-trial-to-efficacy-key-updates/amp-11604213703205.html

India's first COVID-19 vaccine Covaxin to launch in Q2 2021. Phase III trial to efficacy — Updates

Bharat Biotech begun to prepare the site for Phase III trial of Covaxin in India. The recruitment and dosage will begin in November, official added.India's first COVID-19 vaccine is likely to be at least 60% effective

1.4k 0 0

Dr Pulkits ENT Updates

31 Oct 2020, 09:04

https://www.thailandmedical.news/news/university-of-connecticut-study-shows-intranasal-povidone-iodine-limits-covid-19-spread-and-acts-as-prophylaxis-for-medical-staff

COVID-19- Povidone-Iodine: A study led by researchers from the University of Connecticut School of Medicine-Farmington along with experts from The Institute for Antiviral Research at Utah State University, Veloce BioPharma-Florida, ProHealth-Farmington and Ocean Ophthalmology-Florida has demonstrate...

571 0 0

Mepolizumab => a SYNAPSE study revealed that patients with chronic rhinosinusitis associated with nasal polyps benefitted well with an add-on therapy with mepolizumab which was indeed able to reduce both the size of the polyps and the need for surgery. Mepolizumab was developed for the treatment of some diseases driven by eosinophilic inflammation

439 0 0